Health & Family

February 24, 2014

First drug for Charlotte-based Chelsea Therapeutics wins FDA approval

A Charlotte-based pharmaceutical company has received approval from the U.S. Food and Drug Administration to market its first drug, Northera, for treatment of a type of low blood pressure that can affect people with Parkinson’s disease and other neurological disorders.

Related content

Comments

Videos

Entertainment Videos